<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Strategies for encapsulating the active ingredient or drug in a microporous biopolymeric matrix include a single-step impregnation process, as presented by Cabezas et al. [
 <xref rid="B102-pharmaceutics-11-00021" ref-type="bibr" class="xref">102</xref>,
 <xref rid="B103-pharmaceutics-11-00021" ref-type="bibr" class="xref">103</xref>] and via a two-step encapsulation supercritical foaming process [
 <xref rid="B12-pharmaceutics-11-00021" ref-type="bibr" class="xref">12</xref>,
 <xref rid="B13-pharmaceutics-11-00021" ref-type="bibr" class="xref">13</xref>]. The supercritical foaming of biodegradable polymers such as polylactic-
 <italic class="italic">co</italic>-glycolic acid (PLGA) has potential applications for drug delivery and biomedical implants.
</p>
